OncLive TV

Farrukh Awan, MD, discusses the importance of risk stratification in chronic lymphocytic leukemia.

Firas El Chaer, MD, discusses the limitations of JAK inhibitors in myelofibrosis.

Michael J. Cavnar, MD, discusses the roles of chemotherapy and surgery in metastatic colorectal cancer.

The Institutional Perspectives in Cancer webinars assemble academic and community-based physicians and healthcare professionals across key disciplines, ranging from medical to surgical oncology.

Emily C. Ayers, MD, discusses unmet needs in chronic lymphocytic leukemia.

Gagandeep Brar, MD, discusses the rise of new treatment approaches in hepatocellular carcinoma.

Jia Ruan, MD, PhD, discusses the evolving armamentarium ​in mantle cell lymphoma.

R. Lor Randall, MD, FACS, discusses the evolution of orthopedic surgery in sarcoma.

Caitlin Costello, MD, discusses tailoring induction therapy for patients with standard-risk and high-risk multiple myeloma.

Cathy Eng, MD, FACP, FASCO, discusses the role of adjuvant chemotherapy in colorectal cancer.

Deepa Jagadeesh, MD, discusses unmet needs in aggressive and rare lymphoma subtypes.

Reema A. Patel, MD, discusses limitations with chemotherapy in pancreatic cancer.

Naomi B. Haas, MD, discusses the role of prostate-specific membrane antigen in prostate cancer.

Chung-Han Lee, MD, PhD, discusses the rationale for evaluating telaglenastat in renal cell carcinoma.

John Zalcberg, ​PhD, OAM, discusses the approval of avapritinib in gastrointestinal stromal tumor.

Monica L. Baskin, PhD, discusses mitigating patient concerns during the coronavirus disease 2019 pandemic in prostate cancer.

David H. Vesole, MD, PhD, discusses the mechanism of action of belantamab mafodotin-blmf in multiple myeloma.

Nabil F. Saba, MD, FACP, discusses ongoing clinical trials in head and neck cancer.

Nusayba Bagegni, MD, discusses the safety profile of ado-trastuzumab emtansine in early-stage HER2-positive breast cancer.

Joshua Brody, MD, discusses the challenges of mitigating antigen escape in mantle cell lymphoma.

John Zalcberg, ​PhD, OAM, discusses the role of Gastrointestinal Cancer in advanced gastrointestinal stromal tumor​.

Michael J. Cavnar, MD, discusses the importance of multidisciplinary care in colorectal cancer.

Caitlin Costello, MD, discusses treatment selection considerations in multiple myeloma.

Jia Ruan, MD, PhD, discusses the incidence of mantle cell lymphoma.

Alexey V. Danilov, MD, PhD, discusses the role of disease biology in up-front treatment selection in chronic lymphocytic leukemia.

Sarki A. Abdulkadir, MD, PhD, discusses the challenges of targeting MYC in prostate cancer.

Daniel H. Ahn, DO, discusses the role of checkpoint inhibitor therapy in patients with microsatellite instability–high colorectal cancer who harbor an NTRK fusion.

Al B. Benson, MD, discusses the complexity of up-front treatment in hepatocellular carcinoma.

Matthew A. Lunning, DO, discusses initial treatment considerations in chronic lymphocytic leukemia.

Himisha Beltran, MD, discusses the significance of genomic sequencing in prostate cancer.